2-氟-4-硝基苯硼酸频那醇酯 | 1073353-89-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氟-4-硝基苯硼酸频那醇酯
• 中文别名: 2-氟-4-硝基苯基硼酸,频哪醇酯
• 英文名称: 2-(2-fluoro-4-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
• CAS: 1073353-89-5
• 化学式: C₁₂H₁₅BFNO₄
• 分子量: 267.065
• InChiKey: QYXHQOSFZITWSU-UHFFFAOYSA-N

物化性质

• 沸点：
  359.4±32.0 °C(Predicted)
• 密度：
  1.20±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.03
• 重原子数：
  19
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  64.3
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 海关编码：
  2934999090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Fluoro-4-nitrophenylboronic acid, pinacol ester
Synonyms: 2-(2-Fluoro-4-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Fluoro-4-nitrophenylboronic acid, pinacol ester
CAS number: 1073353-89-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H15BFNO4
Molecular weight: 267.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氟-4-硝基苯硼酸频那醇酯 在 5%-palladium/activated carbon 、 氢气 作用下， 以 甲醇 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 4.0h， 以73%的产率得到4-氨基-2-氟苯硼酸频那醇酯
  参考文献：
  名称：

  Sandmeyer型转化合成三甲基锡烷基芳基硼酸酯化合物及其在化学选择性交叉偶联反应中的应用

  摘要：

  描述了一种基于Sandmeyer型反应的合成方法，可从硝基苯胺衍生物中获得锡和硼取代的芳烃。该转化可用于合成一系列官能化的三甲基锡烷基芳基硼酸酯。此外，还探索了Stille和Suzuki-Miyaura交叉偶联反应的化学选择性反应，并通过进行连续的一锅法式Stille和Suzuki-Miyaura交叉偶联反应合成了一系列m-和对-三苯基衍生物。

  DOI：

  10.1021/jo402618r
• 作为产物：
  描述：

  3-氟-4-碘硝基苯 、 联硼酸频那醇酯 在 1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 、 potassium acetate 作用下， 以 二甲基亚砜 为溶剂， 反应 2.5h， 以81.6%的产率得到2-氟-4-硝基苯硼酸频那醇酯
  参考文献：
  名称：

  HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS

  摘要：

  这种应用涉及到式（I）的化合物： 或其药用可接受的盐或立体异构体，这些化合物是PI3K-γ的抑制剂，对于治疗自身免疫疾病、癌症、心血管疾病和神经退行性疾病等疾病是有用的。

  公开号：

  US20180009816A1

文献信息

• Intramolecular aryl–aryl coupling <i>via</i> C–F bond activation tolerant towards C–I functionality
  作者：Ann-Kristin Steiner、Mikhail Feofanov、Konstantin Amsharov

  DOI：10.1039/d0cc06035f

  日期：——

  Herein we report a transition-metal free activation of a particularly stable aromatic carbon–fluorine bond allowing intramolecular aryl–aryl coupling which is orthogonal to carbon–iodine functionality.

  在这里，我们报告了一种无过渡金属参与的活化方法，可以激活特别稳定的芳香族碳-氟键，从而实现分子内芳基-芳基偶联反应，该反应与碳-碘官能团是正交的。
• [EN] COMPOUNDS FOR TREATMENT OF EYE DISORDERS<br/>[FR] COMPOSÉS POUR LE TRAITEMENT DE TROUBLES OCULAIRES
  申请人：SINOPSEE THERAPEUTICS

  公开号：WO2020263187A1

  公开（公告）日：2020-12-30

  Compounds of formula I as defined herein, or pharmaceutically acceptable salts, solvates or derivatives thereof, are potent inhibitors of angiogenesis and accordingly are of use in the treatment and prevention of various angiogenesis-related disorders such as cancer.

  根据此处定义，化学式I所述的化合物，或其药用可接受的盐、溶剂化合物或衍生物，是强效的血管生成抑制剂，因此可用于治疗和预防各种与血管生成相关的疾病，如癌症。
• [EN] TRICYCLIC RHO KINASE INHIBITORS<br/>[FR] INHIBITEURS DE RHO KINASE TRICYCLIQUE
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2018102325A1

  公开（公告）日：2018-06-07

  The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.

  本发明提供了式（I）的化合物：或其立体异构体、互变异构体或药学上可接受的盐，其中所有变量均如本文所定义。这些化合物是选择性ROCK抑制剂。本发明还涉及包含这些化合物的药物组合物以及使用这些药物组合物治疗心血管、平滑肌、肿瘤学、神经病理学、自身免疫、纤维化和/或炎症性疾病的方法。
• Expanding the Palette of Phenanthridinium Cations
  作者：Andrew G. Cairns、Hans Martin Senn、Michael P. Murphy、Richard C. Hartley

  DOI：10.1002/chem.201304241

  日期：2014.3.24

  5,6‐Disubstituted phenanthridinium cations have a range of redox, fluorescence and biological properties. Some properties rely on phenanthridiniums intercalating into DNA, but the use of these cations as exomarkers for the reactive oxygen species (ROS), superoxide, and as inhibitors of acetylcholine esterase (AChE) do not require intercalation. A versatile modular synthesis of 5,6‐disubstituted phenanthridiniums

  5,6-二取代菲啶鎓阳离子具有一系列氧化还原、荧光和生物特性。某些特性依赖于菲啶鎓嵌入 DNA，但使用这些阳离子作为活性氧 (ROS)、超氧化物的外标记以及乙酰胆碱酯酶 (AChE) 的抑制剂不需要嵌入。提出了一种 5,6-二取代菲啶鎓的通用模块化合成方法，通过 Suzuki-Miyaura 偶联、亚胺形成和微波辅助环化引入多样性。密度泛函理论 (DFT) 水平的计算模型表明，无环N -烷基亚胺对芳基卤化物的新置换是通过 S N Ar 机制而不是电环化进行的。研究发现，如果计算始终使用可极化溶剂模型和扩散基组，则卤化物的位移是一致的，并且不存在稳定的迈森海默中间体。
• ARYL AMIDE-BASED KINASE INHIBITORS
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20160016967A1

  公开（公告）日：2016-01-21

  The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.

  本公开涉及一种可以抑制AAK1（适配器相关激酶1）的化合物，包括该化合物的组合物和抑制AAK1的方法。